SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Blue Jet Healthcare - Quaterly Results

29 Oct 2024 Evaluate
The revenue zoomed 14.84% to Rs. 2082.60 millions for the quarter ended September 2024 as compared to Rs. 1813.52 millions during the corresponding quarter last year.Net profit stood at Rs. 583.49  millions  compared to Rs. 478.70 millions in the corresponding previous quarter,high by 21.89%.Operating profit for the quarter ended September 2024 rose to 815.60 millions as compared to 708.37 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 2082.60 1813.52 14.84 3711.59 3608.93 2.84 7115.98 7209.82 -1.30
Other Income 120.74 82.13 47.01 207.89 132.76 56.59 288.60 239.56 20.47
PBIDT 815.60 708.37 15.14 1345.38 1348.56 -0.24 2580.90 2430.45 6.19
Interest 0.21 0.43 -51.16 0.48 0.91 -47.25 1.61 13.59 -88.15
PBDT 815.39 707.94 15.18 1344.90 1347.65 -0.20 2481.86 2416.86 2.69
Depreciation 46.15 64.68 -28.65 80.97 125.18 -35.32 280.91 250.74 12.03
PBT 769.24 643.26 19.58 1263.93 1222.47 3.39 2200.95 2166.12 1.61
TAX 185.75 164.56 12.88 302.67 302.56 0.04 563.44 565.84 -0.42
Deferred Tax 8.25 10.06 -17.99 27.67 4.06 581.53 21.44 7.84 173.47
PAT 583.49 478.70 21.89 961.26 919.91 4.50 1637.51 1600.28 2.33
Equity 346.93 346.93 0.00 346.93 346.93 0.00 346.93 346.93 0.00
PBIDTM(%) 39.16 39.06 0.26 36.25 37.37 -3.00 36.27 33.71 7.59

Blue Jet Healthcare Share Price

407.75 5.15 (1.28%)
15-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.65
Dr. Reddys Lab 1218.30
Cipla 1226.65
Zydus Lifesciences 936.00
Lupin 2339.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×